NO20001926D0 - iso-CBI- og iso-CI-analoger av CC-1065 og duokarmyciner - Google Patents

iso-CBI- og iso-CI-analoger av CC-1065 og duokarmyciner

Info

Publication number
NO20001926D0
NO20001926D0 NO20001926A NO20001926A NO20001926D0 NO 20001926 D0 NO20001926 D0 NO 20001926D0 NO 20001926 A NO20001926 A NO 20001926A NO 20001926 A NO20001926 A NO 20001926A NO 20001926 D0 NO20001926 D0 NO 20001926D0
Authority
NO
Norway
Prior art keywords
iso
duocarmycins
cbi
analogues
Prior art date
Application number
NO20001926A
Other languages
English (en)
Other versions
NO20001926L (no
Inventor
Dale L Boger
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20001926D0 publication Critical patent/NO20001926D0/no
Publication of NO20001926L publication Critical patent/NO20001926L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
NO20001926A 1997-10-14 2000-04-13 Iso-CBI- og iso-CI-analoger av CC-1065 og duocarmycinene NO20001926L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6189297P 1997-10-14 1997-10-14
PCT/US1998/021749 WO1999019298A1 (en) 1997-10-14 1998-10-14 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS

Publications (2)

Publication Number Publication Date
NO20001926D0 true NO20001926D0 (no) 2000-04-13
NO20001926L NO20001926L (no) 2000-06-14

Family

ID=22038819

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001926A NO20001926L (no) 1997-10-14 2000-04-13 Iso-CBI- og iso-CI-analoger av CC-1065 og duocarmycinene

Country Status (9)

Country Link
US (2) US6262271B1 (no)
EP (1) EP1042285A4 (no)
JP (1) JP2001519412A (no)
AU (1) AU756721B2 (no)
CA (1) CA2306420A1 (no)
IL (1) IL135616A0 (no)
NO (1) NO20001926L (no)
NZ (1) NZ503966A (no)
WO (1) WO1999019298A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001525382A (ja) * 1997-12-08 2001-12-11 ザ スクリップス リサーチ インスティテュート Ｃｃ−１０６５／デュオカルマイシン類似体の合成
EP1320522B8 (en) * 2000-09-19 2006-02-01 Moses Lee Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
EP1330459B1 (en) 2000-10-02 2006-08-02 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
WO2002092771A2 (en) 2001-05-11 2002-11-21 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
KR20030033007A (ko) * 2001-05-31 2003-04-26 코울터 파머수티컬, 인코포레이티드 세포독소, 약물전구체, 링커 및 이에 유용한 안정화제
CN100519555C (zh) 2004-03-13 2009-07-29 Tmrc株式会社 将dna的特定碱基序列烷基化的新吲哚衍生物和使用其的烷基化剂以及药剂
CA2564076C (en) * 2004-05-19 2014-02-18 Medarex, Inc. Chemical linkers and conjugates thereof
US7691962B2 (en) * 2004-05-19 2010-04-06 Medarex, Inc. Chemical linkers and conjugates thereof
CN101124249B (zh) * 2005-02-18 2011-06-29 米德列斯公司 抗前列腺特异性膜抗原（psma）的人单克隆抗体
US7714016B2 (en) * 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
BRPI0617546A2 (pt) * 2005-09-26 2011-07-26 Medarex Inc conjugado de fÁrmaco-anticorpo, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula de tumor, mÉtodo para retardar ou interromper o crescimento de um tumor em um sujeito mamÍfero e composto
CA2627046C (en) 2005-10-26 2015-09-15 Medarex, Inc. Methods and compounds for preparing cc-1065 analogs
CA2627190A1 (en) 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
TWI412367B (zh) * 2006-12-28 2013-10-21 Medarex Llc 化學鏈接劑與可裂解基質以及其之綴合物
MX2009007987A (es) * 2007-01-25 2010-03-01 Dana Farber Cancer Inst Inc Uso de anticuerpos anti-egfr en el tratamiento de enfermedad mediada por egfr mutante.
TW200900059A (en) 2007-02-21 2009-01-01 Medarex Inc Chemical linkers with single amino acids and conjugates thereof
US9023356B2 (en) * 2007-03-15 2015-05-05 Ludwig Institute For Cancer Research Ltd Treatment method using EGFR antibodies and SRC inhibitors and related formulations
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
JP5532486B2 (ja) 2007-08-14 2014-06-25 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Ｅｇｆ受容体を標的とするモノクローナル抗体１７５ならびにその誘導体および用途
US8351666B2 (en) 2007-11-15 2013-01-08 General Electric Company Portable imaging system having a seamless form factor
MX2011004625A (es) 2008-11-03 2011-07-20 Syntarga Bv Analogos cc-1065 novedosos y sus conjugados.
US20110076232A1 (en) * 2009-09-29 2011-03-31 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
PL2560645T3 (pl) 2010-04-21 2017-01-31 Syntarga B.V. Koniugaty analogów CC-1065 i łączników dwufunkcyjnych
JP6133431B2 (ja) 2012-11-24 2017-05-24 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． 親水性連結体及び薬物分子と細胞結合分子との共役反応における親水性連結体の使用
SG11201504887TA (en) 2012-12-21 2015-07-30 Bioalliance Cv Hydrophilic self-immolative linkers and conjugates thereof
MY177390A (en) 2014-01-10 2020-09-14 Byondis Bv Method for purifying cys-linked antibody-drug conjugates
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
CN106661124A (zh) 2014-06-20 2017-05-10 荷商台医(有限合伙)公司 抗叶酸受体α(FRA)抗体‑药物缀合物及其使用方法
AU2015242213A1 (en) 2015-07-12 2018-03-08 Hangzhou Dac Biotech Co., Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
EP3400239B1 (en) 2016-01-08 2021-06-02 AltruBio Inc. Tetravalent anti-psgl-1 antibodies and uses thereof
KR20220147720A (ko) 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2076465C (en) * 1992-03-25 2002-11-26 Ravi V. J. Chari Cell binding agent conjugates of analogues and derivatives of cc-1065

Also Published As

Publication number Publication date
JP2001519412A (ja) 2001-10-23
IL135616A0 (en) 2001-05-20
AU1188799A (en) 1999-05-03
NO20001926L (no) 2000-06-14
NZ503966A (en) 2002-10-25
US20020049335A1 (en) 2002-04-25
US6262271B1 (en) 2001-07-17
US6486326B2 (en) 2002-11-26
AU756721B2 (en) 2003-01-23
EP1042285A4 (en) 2002-11-20
CA2306420A1 (en) 1999-04-22
EP1042285A1 (en) 2000-10-11
WO1999019298A1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
NO20001926D0 (no) iso-CBI- og iso-CI-analoger av CC-1065 og duokarmyciner
MA26668A1 (fr) ACTIVATEURS DE hPPARy ET hPPARa
AU3217897A (en) Analogs of cc-1065 and the duocarmycins
IS5341A (is) Samsett meðferð sem inniheldur atórvastatin og þrýstingslækkandi miðil
DK0915880T3 (da) Azolotriaziner og pyrimidiner
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
PL339053A1 (en) Novel derivatives of 2-oxy-pyrimidyn-4-one and pyrimidin-4-thione as fungicides
NO984094L (no) Utladningsreaktor og anvendelse av samme
NO995324L (no) Baerer for gjenstander og emne for denne
FI980246A (fi) Menetelmä keittimen käyttämiseksi ja keitin
NO980718D0 (no) Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer
ID17406A (id) Benda-benda penyerap berpori
NO972103L (no) Eleutherobin og analoger av denne
DE69802692D1 (de) Derivate der chinoloncarbonsäure
DE29608389U1 (de) Personenbeförderungsmittel
NO990832D0 (no) Syntese av bisendolylmalimider
NO20002508D0 (no) Ballastering av halvt nedsenkbar plattform
NO990806L (no) Biologisk nedbrytning av eksplosiver
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
DK1042286T3 (da) Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder
PL338862A1 (en) Derivatives of 2-oxypyroimidin-4-one and 2-oxypyroimidin-4-thione
NO20000038L (no) Benzodiazepinderivater og tilsvarende anvendelse og sammensetning
NO995269D0 (no) Anvendelse av immunmodulerende midler
ID17459A (id) Unsur-unsur pengobatan
UA2072S (uk) Набір блюд

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application